Hospira Bleomycin 15,000 IU Powder for Injection, vial

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

bleomycin sulfate, Quantity: 15000 IU

Disponibbli minn:

Hospira Australia Pty Ltd

INN (Isem Internazzjonali):

bleomycin sulfate

Għamla farmaċewtika:

Injection, powder for

Kompożizzjoni:

Excipient Ingredients:

Rotta amministrattiva:

Intraarterial, Intramuscular, Intraperitoneal, Intravenous, Subcutaneous, Intralesional, Intrapleural

Unitajiet fil-pakkett:

10 x 10 mL vials, 1 x 10 mL vial

Klassi:

Medicine Listed (Export Only)

Tip ta 'preskrizzjoni:

Not scheduled. Not considered by committee

Indikazzjonijiet terapewtiċi:

Squamous cell carcinoma affecting the mouth, nasopharynx, larynx, paranasal sinuses, oesophagus, external genitalia, cervix or skin. Hodgkin's disease and other malignant lymphomas including mycosis fungoides. Testicular teratoma. Malignant effusions of the serous cavities. Metastatic melanoma and the carcinomas of the thyroid, lung and bladder.

Sommarju tal-prodott:

Visual Identification: A white to cream coloured lyophilised powder or plug; Container Type: Vial; Container Life Time: 2 Years

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2006-02-15